Showing results (211-220 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|October 18, 2023
Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brainHiroshi Ikenuma, Aya Ogata, Hiroko Koyama, et al.
EJNMMI Radiopharmacy and Chemistry|June 18, 2026
Automated and manual synthesis of [68Ga]Ga-DOTA-4AH29 intended for PET-imaging of FAP-expressionMarion Berdal, Surasa Nagachinta, Ximena Langsberg, et al.
EJNMMI Radiopharmacy and Chemistry|April 25, 2022
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnologyMartha Sahylí Ortega Pijeira, Herlys Viltres, Jan Kozempel, et al.
EJNMMI Radiopharmacy and Chemistry|April 26, 2026
Radionuclide-based pharmaceuticals for breast cancer imaging: state of the artP Paraïso, C H M van Deurzen, Y Seimbille
EJNMMI Radiopharmacy and Chemistry|April 4, 2026
Comparison of two 18F-fluorinated glycopeptides for PET imaging of the functional liver massMaximilian A Zierke, Katharina Hofer, Kimia Samadikhah, et al.
EJNMMI Radiopharmacy and Chemistry|August 17, 2026
Radiosynthesis and preclinical evaluation of [11C]Methyl-V-0219, a small molecule glucagon-like peptide-1 allosteric modulator for PET brain imagingFrancesco Lechi, Amina Khalil, Pablo Novales Bautista, et al.
EJNMMI Radiopharmacy and Chemistry|September 7, 2026
Development and preclinical evaluation of selective vinyl sulfone-based probes for PET imaging of tumor-associated cathepsinsOliviero Cini, Alan Miranda, Daan Willocx, et al.
EJNMMI Radiopharmacy and Chemistry|November 5, 2022
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMAEline L Hooijman, Carolline M Ntihabose, Thom G A Reuvers, et al.
EJNMMI Radiopharmacy and Chemistry|February 4, 2025
Development of an automated method for in-house production of sodium 18F-fluoride for injection: process validation as a step toward routine clinical applicationMarija Atanasova Lazareva, Maja Chochevska, Katerina Kolevska, et al.
EJNMMI Radiopharmacy and Chemistry|January 10, 2025
Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQKatarína Benčurová, Theresa Balber, Victoria Weissenböck, et al.
Pageof 44